initial public offerings (IPOs) trading on American exchanges

Friday, July 20, 2018

Replimune (REPL) began trading on the Nasdaq on 20 July 2018

Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer.
  • Sector: Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 52
  • Founded in 2015 
  • Headquartered in Woburn, Massachusetts

Replimune priced 6.7 mln share IPO at $15.00, the midpoint of the expected $14.00-16.00 range.
Ppened for trading at $16

No comments:

Post a Comment